Focal Seizures clinical trials

Explore recruiting focal seizures clinical trials.

Recruiting focal seizures studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Focal Seizures trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures

Sweden, Italy, France, Spain, Netherlands, Czechia +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Open-Label Safety and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-onset (Focal) Seizures

Germany, Hungary, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

The ENACT Trial: A Randomized, double-blind, placebo-controlled adjunctive treatment trial to evaluate the efficacy and safety of ENX-101 in patients with focal (partial onset) seizures

Germany, Belgium, Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1)

Spain, Poland, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial Onset Seizures

Spain, Hungary

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures

Poland, Germany, Czechia, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Focal Seizures trials by city

Focal Seizures in Toronto Focal Seizures in Vancouver Focal Seizures in Montreal Focal Seizures in Calgary Focal Seizures in Edmonton Focal Seizures in Ottawa Focal Seizures in Winnipeg Focal Seizures in Quebec City Focal Seizures in Hamilton Focal Seizures in Kitchener Focal Seizures in London Focal Seizures in Halifax Focal Seizures in New York Focal Seizures in Los Angeles Focal Seizures in Chicago Focal Seizures in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease